Madrigal Pharmaceuticals
MDGL
#1687
Rank
NZ$21.23 B
Marketcap
NZ$925.68
Share price
1.22%
Change (1 day)
63.65%
Change (1 year)

Operating Margin for Madrigal Pharmaceuticals (MDGL)

Operating Margin as of April 2026 (TTM): -30.07%

According to Madrigal Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -30.07%. At the end of 2025 the company had an Operating Margin of -30.08%.

Operating Margin history for Madrigal Pharmaceuticals from 2004 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2025-30.08%-88.37%
2024-258.64%
2012-42,714.29%6737.17%
2011-624.74%146.83%
2010-253.10%-553.3%
200955.84%-101.56%
2008-3,583.48%-59.79%
2007-8,911.98%
2004-26,211.56%1108.03%
2003-2,169.79%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
OPKO Health
OPK
-24.83%-17.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-8,391.15% 27,805.39%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.